Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphedema × pirfenidone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Nerve Sheath Neoplasms 1 Lymphedema 1

Interventions

Manual Lymphatic Drainage 3 Low-Level Light Therapy 3 Indocyanine Green 3 pirfenidone 1 pazopanib 1 Technetium Tc 99m Sulfur Colloid 1 Surgical Procedures, Operative 1 Skin Care 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Physical Therapy Modalities 1 Moxibustion 1 Methylene Blue 1 Methods 1 Early Intervention, Educational 1 Drug Therapy 1 Drug Evaluation 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243837 2024-04-23

LYT-100 in Patients With BCRL

PureTech

Phase 2 Terminated

50 enrolled 9 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡